Pharvaris

$17.02 0.00% ($0.00)

Get ready to invest

About Pharvaris

Pharvaris B.V. operates as a clinical-stage company. The Company focuses on the discovery and development of novel oral B2-receptor antagonists for the treatment of patients. Pharvaris serves customers in the Netherlands and Switzerland.

Popular Stocks	Price	Change
AMC AMC	$24.44 4.01%	4.01%
AMD AMD	$100.83 2.76%	2.76%
Nvidia NVDA	$187.09 4.27%	4.27%
Invitae NVTA	$5.37 19.07%	19.07%
Snap SNAP	$11.62 4.59%	4.59%
Bed Bath & Beyond BBBY	$12.95 21.83%	21.83%
Ford F	$16.18 2.21%	2.21%
Apple AAPL	$172.1 2.14%	2.14%
Petróleo Brasileiro S.A. PBR	$13.62 9.74%	9.74%
Amazon AMZN	$143.55 2.07%	2.07%